background
sever
acut
respiratori
syndrom
coronaviru
report
china
januari
effici
transmit
person
person
month
caus
laboratoryconfirm
case
coronaviru
diseas
death
countri
total
number
case
death
surpass
sever
acut
respiratori
syndrom
coronaviru
sarscov
although
sever
acut
respiratori
syndrom
sar
manifest
pneumonia
associ
appar
effici
transmiss
fewer
case
diarrhoea
increas
mental
confus
lower
crude
fatal
rate
howev
underli
virushost
interact
characterist
confer
observ
transmiss
clinic
manifest
remain
unknown
method
systemat
investig
cellular
suscept
speci
tropism
replic
kinet
cell
damag
compar
find
sarscov
compar
sarscov
replic
differ
cell
line
oneway
anova
area
curv
comparison
sarscov
replic
pulmonari
intestin
cell
use
student
test
analys
cell
damag
induc
sarscov
oneway
anova
interpret
far
know
studi
present
first
quantit
data
tropism
replic
kinet
cell
damag
data
provid
novel
insight
lower
incid
diarrhoea
decreas
diseas
sever
reduc
mortal
patient
respect
pathogenesi
high
transmiss
compar
sarscov
wwwthelancetcommicrob
publish
onlin
april
http
doi
coronavirus
envelop
positivesens
singlestrand
rna
virus
infect
wide
rang
human
anim
speci
decemb
six
human
pathogen
coronavirus
known
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
caus
sever
acut
atyp
pneumonia
extrapulmonari
manifest
immuno
compet
immunocompromis
patient
human
coronaviru
usual
caus
mild
selflimit
upper
respiratori
tract
infect
immunocompet
patient
occasion
lower
respiratori
tract
infect
immunocompromis
host
dec
inform
cluster
unexplain
case
pneumonia
wuhan
hubei
provinc
china
subsequ
investig
identifi
novel
lineag
b
betacoronaviru
later
name
sever
acut
respiratori
syndrom
corona
viru
high
degre
genom
similar
bat
coronavirus
typic
clinic
featur
infect
coronaviru
diseas
similar
sever
acut
respiratori
syndrom
sar
includ
fever
myalgia
dri
cough
dyspnoea
fatigu
radiolog
evid
groundglass
lung
opac
compat
atyp
pneumonia
howev
import
clinic
differ
sar
increasingli
recognis
exampl
diarrhoea
seen
much
less
frequent
patient
sar
neurolog
manifest
con
fusion
infrequ
report
patient
almost
absent
patient
sar
anoth
appar
differ
sarscov
speed
outbreak
expand
within
month
number
laboratoryconfirm
case
world
wide
alreadi
exceed
total
number
sar
case
nearli
ten
time
mean
basic
reproduct
number
r
estim
similar
sar
roughli
howev
epicentr
outbreak
hubei
provinc
r
could
high
although
pandem
might
relat
variou
geograph
social
factor
high
popul
densiti
wuhan
massiv
popul
movement
spring
festiv
control
measur
implement
health
author
differ
phase
outbreak
remain
unclear
whether
possess
viral
factor
associ
higher
transmiss
sarscov
shown
sarscov
merscov
emerg
virus
cell
cultur
model
use
characteris
cell
tropism
viral
replic
kinet
virusinduc
cell
damag
profil
novel
virus
date
import
biolog
characterist
infecti
tissu
cell
cultur
remain
incomplet
understood
studi
analys
differenti
suscept
cell
line
deriv
differ
human
organ
tissu
nonhuman
anim
speci
compar
find
sarscov
find
could
provid
potenti
explan
tissu
cultur
level
note
differ
clinic
manifest
transmiss
characterist
sarscov
well
inform
ration
design
diagnost
research
method
evid
studi
search
pubm
feb
term
novel
coronaviru
suscept
tropism
replic
cell
damag
start
date
limit
restrict
search
articl
publish
english
search
identifi
origin
research
articl
investig
suscept
tropism
replic
cytotox
sever
acut
respiratori
syndrom
coronaviru
investig
cell
suscept
speci
tropism
replic
kinet
virusinduc
cell
damag
sever
acut
respiratori
syndrom
coronaviru
sarscov
use
live
infecti
viru
particl
replic
effici
sarscov
human
pulmonari
cell
contrast
sarscov
replic
effici
rhinolophu
sinicu
bat
kidney
cell
moreov
consist
found
induc
less
cell
damag
sarscov
nonhuman
primat
kidney
cell
find
provid
possibl
explan
effici
persontoperson
transmiss
coronaviru
diseas
like
adapt
well
human
thu
longer
abl
propag
well
bat
cell
replic
high
level
without
induc
substanti
host
cell
damag
furthermor
replic
similarli
effici
human
intestin
pulmonari
cell
sarscov
replic
significantli
better
intestin
pulmonari
cell
differ
might
account
diarrhoea
report
much
less
frequent
patient
infect
sarscov
sarscov
also
modestli
replic
neuron
cell
highlight
potenti
viru
caus
neurolog
manifest
eg
confus
anosmia
ageusia
patient
final
replic
effici
nonhuman
primat
cat
rabbit
pig
cell
result
would
use
develop
anim
model
find
provid
explan
tissu
cell
cultur
level
differ
clinic
manifest
transmiss
sarscov
data
use
optimis
anim
model
laboratori
method
isol
nasopharyng
aspir
specimen
taken
patient
hong
kong
laboratoryconfirm
inocul
nasopharyng
aspir
specimen
nonhuman
primat
kidney
cell
without
trypsin
monitor
inocul
cell
daili
cytopath
effect
light
microscopi
collect
cell
supernat
daili
quantit
rtpcr
assess
viral
load
substanti
cytopath
effect
seen
h
postinocula
tion
hpi
confirm
posit
replic
quan
tit
rtpcr
use
specif
primer
probe
panel
wholegenom
sequenc
isol
use
oxford
nanopor
minion
devic
oxford
nanopor
tech
nolog
oxford
uk
supplement
sanger
sequenc
previous
describ
sequenc
com
parison
clinic
isol
shown
appendix
pp
sarscov
clinic
isol
archiv
depart
microbiolog
univers
hong
kong
genbank
access
number
sarscov
propag
titr
ascertain
cell
plaqu
assay
virus
passag
three
time
use
experi
experi
entail
live
sarscov
follow
approv
standard
oper
procedur
biosafeti
level
facil
three
nucleotid
sequenc
genbank
access
number
two
nucleotid
sequenc
sarscov
first
align
use
muscl
use
align
sequenc
determin
best
model
phylogenet
analysi
use
mega
x
inocul
cell
line
deriv
differ
tissu
organ
host
speci
forward
primer
sarscov
acut
respiratori
syndrom
coronaviru
sarscovsever
acut
respiratori
syndrom
coronaviru
sarscov
multipl
infect
moi
h
depend
cell
type
maintain
cell
minimum
essenti
medium
gibco
waltham
usa
dulbecco
modifi
eagl
medium
dmem
gibco
gibco
accord
supplier
instruct
cell
line
use
routin
test
mycoplasma
maintain
mycoplasmafre
harvest
supernat
sampl
infect
cell
hpi
hpi
hpi
hpi
quantit
rtpcr
analysi
viru
replic
previous
describ
briefli
lyse
viral
supernat
extract
total
rna
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
use
realtim
quantit
rtpcr
quantifi
sarscov
replic
use
quantinova
probe
rtpcr
kit
qiagen
lightcycl
realtim
pcr
system
roch
basel
switzerland
reaction
mixtur
contain
quantinova
probe
rtpcr
master
mix
qiagen
rnasefre
water
quantinova
probe
rtmix
qiagen
forward
revers
primer
probe
extract
rna
templat
incub
reaction
min
revers
transcript
min
denatur
follow
cycl
detect
measur
signal
cycl
anneal
step
cycl
profil
end
cool
step
primer
probe
sequenc
rnadepend
rna
polymeras
helicas
gene
region
sarscov
panel
prepar
antibodi
nucleocapsid
protein
np
mix
purifi
recombin
protein
equal
volum
complet
freund
adjuv
sigmaaldrich
st
loui
mo
usa
inject
mixtur
subcutan
new
zealand
white
rabbit
use
incomplet
freund
adjuv
sigmaaldrich
three
subsequ
inject
interv
obtain
serum
sampl
third
inject
titrat
immun
serum
coat
immunopl
nunc
immuno
modul
nunc
denmark
per
well
per
well
moll
nahco
ph
overnight
follow
incub
block
reagent
block
ad
well
serialdilut
immunis
rabbit
sarscovnp
serum
start
dilut
incub
plate
h
plate
wash
ad
horseradish
peroxidaselabel
goat
antirabbit
antibodi
invitrogen
carlsbad
ca
usa
per
well
incub
plate
min
incub
wash
well
ad
solut
invitrogen
min
reaction
time
stop
reaction
well
n
sulphur
acid
read
optic
densiti
nm
plate
reader
perkin
elmer
waltham
usa
detect
antigen
express
cell
use
inhous
rabbit
antiserum
label
cell
nuclei
dapi
nucleic
acid
stain
thermofish
scientif
waltham
usa
secondari
antibodi
alexa
fluor
thermofish
scientif
mount
done
diamond
prolong
antifad
mountant
thermofish
scientif
acquir
imag
confoc
microscopi
use
carl
zeiss
system
zeiss
oberkochen
germani
oil
immer
sion
object
previous
describ
ascertain
cell
damag
sarscov
infect
quantifi
cell
viabil
celltiterglo
assay
promega
madison
wi
usa
lyse
cell
togeth
cultur
supernat
ratio
volum
celltiterglo
reagent
incub
mixtur
room
temperatur
min
measur
luminesc
signal
vector
multilabel
plate
reader
perkin
elmer
obtain
imag
cellular
cytopath
effect
sarscov
infect
hpi
nikon
invert
microscop
nikon
tokyo
japan
preincub
sarscov
recombin
human
angiotensinconvert
enzym
ace
r
system
minneapoli
mn
usa
h
ad
mixtur
cell
min
subsequ
wash
cell
incub
fresh
medium
h
cell
lysat
harvest
quantit
rtpcr
analysi
viru
genom
copi
compar
sarscov
replic
differ
cell
line
oneway
anova
area
curv
auc
comparison
sarscov
replic
pulmonari
intestin
cell
use
student
test
analys
cell
damag
induc
sarscov
oneway
anova
analys
done
graphpad
prism
version
graphpad
san
diego
ca
usa
judg
differ
statist
signific
p
valu
less
funder
role
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
studi
final
respons
decis
submit
public
nine
human
cell
line
test
tabl
five
suscept
infect
shown
signific
viru
replic
period
h
figur
among
suscept
cell
line
replic
robust
pulmonari
intestin
cell
follow
hepat
renal
cell
furthermor
modest
replic
detect
neuron
cell
gener
cellular
tropism
similar
sarscov
also
show
signific
viru
replic
cell
cell
figur
although
sarscov
show
higher
replic
capac
cell
cell
log
differ
hpi
replic
effici
cell
log
differ
hpi
find
support
auc
analysi
show
total
viru
product
cell
infect
significantli
higher
sarscov
total
viru
product
cell
infect
sarscov
significantli
higher
h
period
figur
differ
sarscov
replic
cell
valid
assay
ascertain
median
tissu
cultur
infecti
dose
appendix
p
overal
despit
sarscov
share
similar
profil
cellular
tropism
two
virus
might
differ
capac
infect
replic
pulmonari
intestin
neuron
cell
nonhuman
cell
line
test
tabl
six
suscept
infect
period
figur
replic
robustli
nonhuman
primat
cell
pig
cell
shown
log
greater
increas
mean
viral
load
period
h
cell
similar
human
cell
tropism
profil
cellular
tropism
nonhuman
cell
larg
match
sarscov
also
capabl
infect
replic
nonhuman
primat
cat
rabbit
pig
cell
figur
importantli
sarscov
could
replic
rhinolophu
sinicu
primari
bat
kidney
cell
rsk
recombin
human
protein
block
assay
confirm
similar
sarscov
infect
depend
appendix
p
addit
cellular
tropism
replic
kinet
profil
cell
damag
induc
also
assess
nine
human
figur
nonhuman
figur
cell
line
among
cell
line
support
replic
crfk
induc
substanti
cell
damag
cell
viabil
hpi
p
cell
viabil
hpi
p
typic
cytopath
effect
cell
includ
cell
round
detach
degener
syncytium
format
figur
despit
robust
replic
cell
substanti
cell
death
detect
hpi
hpi
viabil
viabil
understand
would
induc
cell
death
cell
support
effici
viru
replic
delay
timepoint
cell
viabil
cell
assess
day
postinfect
cell
death
detect
cell
type
appendix
p
although
sarscov
inocul
moi
induc
less
cell
damag
sarscov
figur
observ
support
significantli
higher
percentag
cell
viabil
cell
infect
infect
sarscov
multipl
timepoint
auc
analysi
also
show
parallel
viral
replic
assay
antigen
express
detect
sever
repres
cell
type
use
antiserum
antibodi
appendix
p
immunostain
confoc
microscopi
could
abundantli
detect
earli
hpi
appear
diffus
distribut
across
cytoplasm
infect
cell
appendix
p
abund
antigen
express
correspond
viral
replic
kinet
appendix
p
abund
express
detect
cell
line
support
replic
includ
cell
contrast
viral
antigen
express
detect
nonsuscept
cell
inocul
figur
past
month
public
observ
studi
clinic
cohort
epidemiolog
investig
forecast
insilico
genom
structur
analys
mani
basic
virolog
question
remain
unansw
studi
systemat
compar
differenti
cell
tropism
viral
replic
kinet
cell
damag
profil
sarscov
data
show
biolog
characterist
might
provid
insight
understand
viru
uniqu
clinic
manifest
transmiss
rationalis
laboratori
diagnost
expect
use
human
entri
receptor
sarscov
show
signific
replic
pulmonari
cell
correspond
abil
coronavirus
caus
lower
respiratori
tract
infect
contrast
primarili
caus
selflimit
upper
respiratori
tract
infect
replic
effici
cell
replic
compar
level
intestin
cell
wherea
sarscov
replic
significantli
effici
cell
moi
find
support
higher
incid
diarrhoea
patient
sar
patient
among
patient
report
four
larg
clinic
cohort
develop
diarrhoea
contrast
diarrhoea
common
extrapulmonari
clinic
manifest
sar
report
sar
patient
clinic
deterior
sar
commonli
occur
week
symptom
onset
typic
accompani
noninflammatori
wateri
diarrhoea
mean
viral
load
stool
specimen
sar
patient
log
copi
per
ml
higher
nasopharyng
aspir
specimen
day
symptom
onset
among
nonpulmonari
cell
line
sarscov
show
signific
replic
hepat
renal
cell
patient
sar
patient
develop
hepat
dysfunct
patient
need
intens
care
significantli
higher
amount
hepat
aminotransferas
need
intens
care
term
renal
manifest
patient
develop
acut
kidney
injuri
need
renal
replac
therapi
similarli
sar
patient
develop
acut
renal
impair
associ
significantli
higher
mortal
rate
without
acut
renal
impair
vs
p
prognost
valu
hepat
renal
dysfunct
patient
investig
data
show
modest
replic
sarscov
neuron
cell
find
might
correl
observ
patient
develop
confus
dizzi
ness
report
anosmia
ageusia
wherea
neurolog
manifest
rare
report
sar
patient
potenti
directli
infect
cn
need
closer
scrutini
anoth
betacoronaviru
associ
fatal
enceph
boy
sever
combin
immuno
defici
data
also
provid
new
insight
appar
high
transmiss
auc
analysi
show
effici
replic
cell
sarscov
sarscov
use
human
cell
entri
receptor
howev
spike
protein
subunit
two
virus
share
approxim
amino
acid
ident
signific
amino
acid
differ
sarscov
locat
ectodomain
spike
protein
import
receptor
bind
find
studi
show
bind
affin
spike
ectodomain
human
approxim
higher
bind
affin
sarscov
spike
ectodomain
human
higher
receptorbind
capac
might
facilit
viru
entri
pulmonari
cell
lead
effici
persontoperson
transmiss
direct
indirect
contact
respiratori
droplet
patient
although
sarscov
show
similar
tropism
nonhuman
cell
line
deriv
variou
anim
speci
sarscov
show
signific
replic
rsk
cell
other
previous
identifi
r
sinicu
like
natur
anim
reservoir
sarslik
coronaviru
postul
origin
r
sinicu
bat
viru
phylogenet
close
relat
coronavirus
found
bat
find
rais
possibl
alreadi
adapt
well
human
thu
viru
longer
abl
propag
well
r
sinicu
bat
cell
provid
possibl
explan
effici
persontoperson
transmiss
cell
cultur
model
data
use
optimis
laboratori
method
studi
first
show
replic
effici
nonhuman
primat
cat
crfk
rabbit
pig
cell
nonhuman
primat
includ
rhesu
macaqu
cynomolgu
macaqu
african
green
monkey
common
marmoset
suscept
infect
sarscov
merscov
virus
sarscovinfect
domest
cat
develop
asymptomat
infect
viru
shed
pharynx
day
post
infect
similarli
merscovinfect
rabbit
domest
pig
also
develop
asymptomat
viru
shed
respiratori
tract
suscept
mice
transgen
human
infect
assess
anim
model
develop
could
recapitul
differ
diseas
sever
human
rang
asymptomat
fatal
infect
second
data
show
abund
antigen
express
correl
viral
replic
kinet
although
immunofluoresc
antigen
test
gener
lower
sensit
rtpcr
assay
nonlabourintens
diagnost
could
consid
screen
test
laboratori
without
resourc
expertis
rtpcr
assay
final
data
show
among
cell
line
assess
cytopath
effect
seen
cell
inocul
hpi
find
import
optimis
antivir
assay
base
cell
protect
assess
cell
line
without
obviou
cytopath
effect
might
lead
overestim
cell
viabil
drug
efficaci
studi
sever
limit
first
cell
line
tropism
might
fulli
repres
replic
affect
human
organ
physiolog
state
thu
cell
line
suscept
result
clinic
manifest
patient
might
complet
accord
essenti
characteris
virushost
interact
physiolog
model
exvivo
human
organ
tissu
human
organoid
patient
differ
age
sex
underli
diseas
nevertheless
find
cell
line
suscept
studi
merscov
highli
corrobor
seen
patient
mer
second
experi
use
one
viral
isol
highli
homolog
report
isol
isol
addit
amino
acid
mutat
particularli
involv
receptor
bind
domain
studi
identifi
viral
factor
might
affect
viru
entri
host
cell
viru
replic
kinet
final
viral
kinet
human
cell
line
eg
cardiomyocyt
anim
cell
line
assess
investig
virusinduc
damag
cardiac
cell
potenti
anim
reservoir
hc
jfwc
kyy
contribut
studi
design
data
collect
data
analysi
data
interpret
write
report
ttti
hs
sy
yw
bh
ccyy
jolt
xh
yc
dy
yh
kkhc
xz
ayff
hwt
jpc
wmc
jdi
awhc
jz
dcl
khk
kkwt
otyt
khc
contribut
experi
data
collect
data
analysi
data
interpret
author
review
approv
final
version
report
declar
compet
interest
